VOR ▲ +1.8% - Vor Biopharma Inc. $VOR - Telitacicept Demonstrates Deep and Durable Minimal Symptom Expression Through 48 Weeks in Generalized Myasthenia Gravis 29-SEP-2026 08:05 AM ET